MRK vs WST
By Alex · Tickerpine
Merck & Co., Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | WST |
|---|---|---|
| Price | $148.69 | $375.65 |
| Market cap | $366.84B | $26.44B |
| P/E ratio | 119.0 | 48.0 |
| ROE | 6.96% | 19.09% |
| Profit margin | 4.77% | 16.98% |
| Revenue growth | 5.10% | 13.80% |
| Dividend yield | 2.29% | 0.23% |
| Beta | 0.23 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs WST in plain English
- MRK is the bigger company — about 13.9× the market cap of WST.
- WST is cheaper on earnings (P/E 48.0 vs 119.0).
- WST earns a higher return on equity (19% vs 7%).
- WST is growing revenue faster (14% vs 5%).
- MRK has the higher dividend yield (2.29% vs 0.23%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.